| Read Time: < 1 minute | Dangerous Drugs

Schedule For Zantac Discovery and Case Management

June 18, 2020 — On June 18, 2020,  Judge Rosenberg ordered a schedule for discovery and case management in Pretrial Order #30.  The schedule runs from June 15, 2020, which was the beginning of fact discovery, to August 3, 2022. Reference:  “United States District Court.” 20-MD-2924-Rosenberg – In Re: Zantac (Ranitidine) Products Liability Litigation | Southern District of Florida | United States District Court, 31 Dec. 2020, www.flsd.uscourts.gov/zantac.

Continue Reading

| Read Time: < 1 minute | Dangerous Drugs

California Plaintiffs Seek to Consolidate Zantac Lawsuits

June 9, 2020 – Forty previous Zantac users with cancer asked a court to consolidate their cases in California. The plaintiffs were alleging that Sanofi-Aventis US LLC, Pfizer Inc., and other pharmaceutical companies hid the risks of heartburn drug Zantac. Linking their cases in a coordinated proceeding to consolidate pretrial and trial phases of the cases would align all of the existing cases against the same manufacturers and allow all of the parties to work alongside the Zantac Florida MDL headed by U.S. District Judge Robin Rosenberg.  One of the plaintiffs is the mother of an 8-year-old boy who alleges that her use of Zantac while pregnant resulted in her son developing testicular cancer. Other complaints allege the drug also resulted in bladder, kidney, prostate, and thyroid cancer. Also, the plaintiffs’ complaints allege that, despite knowing the risks associated with taking Zantac, the companies failed to warn its users and advertised that the drug was safe to take while eating with the foods that would cause the development of the carcinogen. The lawsuits further claim that GlaxoSmithKline LLC, the first manufacturer of Zantac in the 1970s, worked to discredit studies in the 1980s that showed the drug’s hazardous potential. GSK said it takes the issue very seriously as patient safety is its utmost priority. Reference: Law360 09 Jun 2020, www.law360.com/articles/1281440/zantac-users-push-to-consolidate-calif-cancer-suits

Continue Reading

| Read Time: < 1 minute | Dangerous Drugs

Warning Label Change Allows for Dismissal for 200 Taxotere Cases

May 27, 2020 — U.S. District Judge Jane Triche Milazzo dismissed nearly 200 lawsuits by patients, saying the change in the drug’s warning label in 2015 clearly explained its risks.  She ruled that the updated Taxotere label was legally adequate as it warned about the risk of the permanent hair loss patients suffered.  Judge Milazzo explained that the label “clearly and consistently” explained the risk following the December 2015 change by including reports of permanent alopecia in the adverse reactions section and by advising doctors to inform patients of the side effect.  Judge Milazzo also stated that the plaintiffs’ lawyers did not provide evidence that supported the risk of permanent alopecia needing to be included in a specific section of the label. At this time, there were 12,690 Taxotere cases pending before Judge Milazzo in the MDL against drug manufacturers that included Sanofi. Reference: Raymond, Nate. “Warning Label Change for Sanofi’s Taxotere Dooms 200 Hair Loss Cases – Judge.” Reuters, Thomson Reuters, 28 May 2020, www.reuters.com/article/products-taxotere/warning-label-change-for-sanofis-taxotere-dooms-200-hair-loss-cases-judge-idUSL1N2DA1ZO

Continue Reading

| Read Time: < 1 minute | Dangerous Drugs

Taxotere Trial Schedule Update May 5, 2020

May 5, 2020 — “The Court reset the second bellwether trial for October 19, 2020.” Reference: “United States District Court.” MDL – 2740 Taxotere (Docetaxel) Products Liability Litigation | Eastern District of Louisiana | United States District Court, 28 Dec. 2020, www.laed.uscourts.gov/case-information/mdl-mass-class-action/taxotere

Continue Reading

| Read Time: < 1 minute | Dangerous Drugs

FDA Orders Removal Of Ranitidine Products

April 1, 2020 — On April 1, 2020, the FDA ordered the removal of all ranitidine products from the market. Reference:  “FDA Requests Removal of All Ranitidine Products (Zantac) from the Market.” U.S. Food and Drug Administration, FDA, www.fda.gov/news-events/press-announcements/fda-requests-removal-all-ranitidine-products-zantac-market.

Continue Reading

| Read Time: < 1 minute | Dangerous Drugs

Order For Zantac Census

April 2, 2020 — On April 2, 2020, Judge Rosenberg ordered a 2 part census of Zantac claims in Pretrial Order #15.  The first part of the census was meant to relay how many cases are in MDL 2924.  The second part was meant to relay what the allegations of Zantac use and damages are, requiring information from attorneys and plaintiffs. Reference:  “United States District Court.” 20-MD-2924-Rosenberg – In Re: Zantac (Ranitidine) Products Liability Litigation | Southern District of Florida | United States District Court, 31 Dec. 2020, www.flsd.uscourts.gov/zantac.

Continue Reading

| Read Time: < 1 minute | Dangerous Drugs

Taxotere Lawsuit Number Update March 2020

March 2020 — Sanofi said it faced lawsuits by 10,628 plaintiffs in federal court as well as state courts in New Jersey, California, and Delaware in March 2020. Reference: Raymond, Nate. “Warning Label Change for Sanofi’s Taxotere Dooms 200 Hair Loss Cases – Judge.” Reuters, Thomson Reuters, 28 May 2020, www.reuters.com/article/products-taxotere/warning-label-change-for-sanofis-taxotere-dooms-200-hair-loss-cases-judge-idUSL1N2DA1ZO

Continue Reading

| Read Time: < 1 minute | Dangerous Drugs

Major Zantac Seller Down $186M Amidst Lawsuits

February 17, 2020 – Sanofi has taken a $186 million write-off for Zantac after recalling it back in October 2019. The following companies have now recalled a version of Zantac: Sanofi Golden State Medical Supply Novitium Pharma Amneal Northwind Pharmaceuticals (a.k.a. Denton Pharma) Sandoz (pharma division of Novartis) Appco Pharma Apotex Perrigo Lannett Company Aurobindo Also, Walgreens and CVS have stopped selling Zantac. Reference: Blankenship, Kyle. “Sanofi Takes $186M Hit on the Heels of Zantac Recall.” Fierce Pharma, 06 Feb. 2020, https://www.fiercepharma.com/manufacturing/sanofi-takes-a-big-financial-hit-after-recall-contaminated-zantac; www.sanofi.com/-/media/Project/One-Sanofi-Web/Websites/Global/Sanofi-COM/Home/en/investors/docs/2019_Q4_Press_Release_EN.pdf.

Continue Reading

| Read Time: < 1 minute | Dangerous Drugs

MDL Consolidation For Zantac Cases

February 6, 2020 — On February 6, 2020, the Judicial Panel on Multidistrict Litigation transferred over 140 Zantac lawsuits to Judge Robin Rosenberg in Miami under MDL No. 2924.  Since then, over 400 additional cases have joined MDL 2924.  Judge Rosenberg had not previously handled an MDL and was appointed by President Obama. References:  Rosenberg, Judge Robin. In Re Zantac (Ranitidine) Prods. Liab. Litig., 31 July 2020, www.casetext.com/case/in-re-zantac-ranitidine-prods-liab-litig. “Zantac Lawsuit Leads for Attorneys: Drug Injury.” Broughton Partners, 12 Jan. 2021, www.broughtonpartners.com/products/zantac-lawsuit-leads-for-attorneys/#product_updates.

Continue Reading

| Read Time: < 1 minute | Dangerous Drugs

New Zantac Lawsuits Cover Stomach Cancer, Colon Cancer, and More

January 29, 2020 – New lawsuits are emerging as the public learns more about the alleged adverse effects of taking Zantac. Victims are now claiming it has caused stomach cancer, colon cancer, and even leukemia. These are in addition to the already-extensive list of illnesses being attributed to the drug. Just a few months ago, the FDA warned the public that ranitidine, commonly sold under the name “Zantac,” has been found to contain unsafe levels of the carcinogen N-nitrosodimethylamine (NDMA). Since then, at least nine different companies that sell Zantac or a generic version of Zantac have voluntarily issued recalls for the drug. Interestingly, NDMA is no longer made in the US. The FDA believes the NDMA found in Zantac is just a chemical impurity, but some plaintiffs are arguing that NDMA is actually formed in the body upon consumption. The latter suggests anybody could be injured by the drug, regardless of where or when they bought it. Reference: TorHoerman Law, LLC, www.torhoermanlaw.com/personal_injury_lawsuit/bad_drug_lawsuit/zantac-lawsuit/

Continue Reading